Compared to the tumor-bearing control, ATRA treatment alone significantly decreased the differentiation of Th2 cells and Tregs, but the expression level of perforin in CD4+ T cells was obviously decreased; furthermore, the Th1 subset showed a decreasing trend (Figure 4A). This evidence concerns the gene PRF1 and neoplasm.